Vis enkel innførsel

dc.contributor.authorVislapuu, Maarjaen_US
dc.contributor.authorBrostrøm, Andersen_US
dc.contributor.authorIgland, Jannickeen_US
dc.contributor.authorVorderstrasse, Allisonen_US
dc.contributor.authorIversen, Marjolein M.en_US
dc.date.accessioned2019-12-19T11:58:23Z
dc.date.available2019-12-19T11:58:23Z
dc.date.issued2019
dc.PublishedVislapuu M, Brostrøm A, Igland J, Vorderstrasse, Iversen M.M.. Psychometric properties of the Norwegian version of the short form of the Problem Areas in Diabetes scale (PAID-5): A validation study. BMJ Open. 2019;9:e022903eng
dc.identifier.issn2044-6055
dc.identifier.urihttps://hdl.handle.net/1956/21189
dc.description.abstractObjectives To assess the psychometric properties of the short form of The Problem Areas in Diabetes scale (PAID-5) in Norwegian adult patients with type 1 or type 2 diabetes. Design Cross-sectional survey design. Methods Participants (n=143) were included from three Western-Norway endocrinology outpatient clinics. Demographic and clinical data were collected in addition to questionnaires concerning diabetes-related distress, fear of hypoglycaemia, symptoms of depression, emotional well-being and perception of general health. Psychometric evaluation of the PAID-5 included confirming its postulated one-factor structure using confirmatory factor analysis (CFA) and assessing convergent validity, discriminant validity, internal consistency and test-retest reliability. The retest questionnaire was sent out 35±15 days after the initial assessment to those who agreed (n=117). Results The CFA for the PAID-5 scale showed excellent one-factor structure, and there was high internal consistency (α=0.89) and good test-retest reliability (Intraclass Correlation Coefficient, ICC=0.81). The PAID-5 correlated positively with fear of hypoglycaemia (r=0.598) and depression (r=0.380) and negatively with emotional well-being (r=−0.363) and perception of general health (r=−0.420), thus satisfying convergent validity. Patients who had experienced episodes of serious hypoglycaemia in the past 6 months had a significantly higher PAID-5 mean score (7.5, SD=4.95) than those who had not had these episodes (5.0, SD=4.2 (p=0.043)). Conclusion The Norwegian PAID-5 was shown to be a reliable and valid short questionnaire for assessing diabetes-related distress among people with type 1 or type 2 diabetes. However, its ability to discriminate between groups needs to be tested further in larger samples. The PAID-5 scale can be a particularly valuable screening instrument in outpatient clinics, as its brevity makes it easy to use as a tool in patient-provider encounters. This short questionnaire is useful in the national diabetes registry or population cohort studies as it enables increased knowledge regarding the prevalence of diabetes-related distress.en_US
dc.language.isoengeng
dc.publisherBMJeng
dc.rightsAttribution CC BY-NCeng
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/eng
dc.titlePsychometric properties of the Norwegian version of the short form of the Problem Areas in Diabetes scale (PAID-5): A validation studyen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2019-08-15T12:29:40Z
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2019 The Author(s)
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2018-022903
dc.identifier.cristin1705427
dc.source.journalBMJ Open


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY-NC
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY-NC